On 16th July The Prostate Cancer Charity, in partnership with the Royal Society of Medicine (RSM) and the Prostate Cancer Charter for Action delivered an afternoon conference on prostate cancer as part of the RSM’s ‘Medicine and Me’ series.
The Conference was attended by nearly 200 people affected by prostate cancer and health professionals and focused on the current status of research into treatments for prostate cancer and access to clinical trials.
For further information on clinical trials, please read our factsheet: “A Guide to prostate cancer clinical trials”.
Following an introduction by Dr Chris Parker of The Institute of Cancer Research, the afternoon was split into three sessions, two of which dealt with different stages of prostate cancer, with the third session reviewing the possible beneficial effect of diet and complementary therapies.
To hear a recording of these sessions, please click on the relevant section below:
Introduction MP3 Track
Dr John Scadding, Dean, Royal Society of Medicine
Challenges in Prostate Cancer Research Powerpoint slides | MP3 Track
Dr Chris Parker, Royal Marsden Hospital, London
Localised Disease MP3 Track
Chair: Prof. Jonathan Waxman, Hammersmith Hospital, London
Personal perspective: Richard Carter
What research is telling us: Prof Freddie Hamdy, Royal Hallamshire Hospital, Sheffield
Hormone Refractory Metastatic Disease MP3 Track
Chair: Mike Birtwistle, Prostate Cancer Charter for Action
Personal perspective: Ian Liston
What research is telling us: Dr Stephen Harland, University College Hospital, London
Research into living with prostate cancer (including diet and complementary thereapies) MP3 Track
Chair: John Neate, Chief Executive, The Prostate Cancer Charity
Personal perspective: Peter Loader
What research is telling us: Prof. Kenneth Muir, University of Nottingham Medical School
Panel Discussion MP3 Track
Closing remarks: John Neate, CEO, The Prostate Cancer Charity
